This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: B.a.i. Laboratories, LLC, Beijing Xiaomi Mobile Software Co., Ltd., Chinese Academy of Sciences. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 3,012 
1 out of 3,363 
Years Active: 2019-2024
Title: Innovations and Contributions of Inventor Sheng Lin
Introduction
Sheng Lin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of therapeutic compounds, holding a total of 4 patents. His work focuses on developing innovative solutions for treating various medical conditions.
Latest Patents
One of Sheng Lin's latest patents is titled "Interleukin-13 binding cyclic oligopeptides and methods of use thereof." This patent relates to cyclic oligopeptides that bind to interleukin-13 (IL-13), which are therapeutically useful in treating or preventing IL-13-associated skin disorders. The patent also outlines methods for producing these IL-13-binding cyclic oligopeptides. Another notable patent is for "Pyrroloquinolin compounds and methods of using same." This patent provides pyrroloquinolin compounds that are therapeutic, particularly for treating cell proliferative disorders. It also includes compositions and therapeutic methods involving these compounds.
Career Highlights
Sheng Lin has worked with notable organizations such as Beijing Xiaomi Mobile Software Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Sheng Lin has collaborated with esteemed colleagues, including Jiangong Shi and Jianjun Zhang. These collaborations have further enhanced his research and development efforts in the field of therapeutic compounds.
Conclusion
Sheng Lin's innovative work and patents reflect his dedication to advancing medical therapies. His contributions are significant in the realm of treating skin disorders and cell proliferative disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile